Recent

% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

palantir777 91 posts  |  Last Activity: 11 hours ago Member since: Sep 3, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    so So Easy

    by rainingdung 12 hours ago
    palantir777 palantir777 11 hours ago Flag

    Nonsensical gobbledygook as only you may post pup_puta cuckaracha poquita! the ever entertaining lowest of lowbars, u da man!

    Sentiment: Buy

  • palantir777 palantir777 17 hours ago Flag

    lol, even the pup_puta/dungforbrains impostor is as much an idiot as the original. i guess expecting more for a nickel a throw is a bit preposterous...

    ymbacc • Jul 1, 2015 11:11 PM Flag
    1users liked this postsusers disliked this posts0Reply
    Like the 1st of every month.
    Don't be surprised if you a see a Form 4 filed tomorrow after hours. Larson will have sold some shares today according to his trading plan.

    According to the plan, these sales will keep happening throughout Dec 2015 and they're for 12.5% of his position. It's not like he's selling out. Please see below quoted directly from the SEC filing taken from the 8K filed on March 19th.

    "Pursuant to the terms of the Plan, Mr. Larson's brokers may sell up to 120,000 shares of the Company's common stock ("Common Stock") held by Mr. Larson, including Common Stock to be acquired upon the exercise of stock options. Mr. Larson is entering the Plan in part to satisfy tax obligations resulting from the exercise of previously granted stock options, but also for longer term diversification purposes. The shares that may be sold under the Plan represent approximately 12.5% of Mr. Larson's equity holdings in the Company as of February 28, 2015 (including vested and unvested stock options). The Plan will commence on April 1, 2015 and end on December 31, 2015, and sales will be made ratably over that period."

    Sentiment: Buy

  • Reply to

    Like the 1st of every month.

    by ymbacc Jul 1, 2015 11:11 PM
    palantir777 palantir777 17 hours ago Flag

    thanks for the reminder ymbacc.....

    Sentiment: Buy

  • Reply to

    friday stocks open down

    by rainingdung 22 hours ago
    palantir777 palantir777 17 hours ago Flag

    markets in the U.S. CLOSED pup_puta, another wasted bash by this mb`s preeminent moron(not to worry pat as that you`re in the top 3).....but still entertaining as ever!

    2015 Market Holidays and Half-Days
    NYSE NASDAQ SIFMA (Bond Market)*
    New Year's Eve -- December 31, 2014 OPEN OPEN REC. 2:00 P.M. CLOSE
    New Year's Day -- January 1, 2015 CLOSED CLOSED REC. CLOSE
    Martin Luther King Jr. Day -- January 19, 2015 CLOSED CLOSED REC. CLOSE
    Washington's Birthday -- February 16, 2015 CLOSED CLOSED REC. CLOSE
    Thursday -- April 2, 2015 OPEN OPEN OPEN
    Good Friday -- April 3, 2015 CLOSED CLOSED REC. 12 P.M. CLOSE
    Friday -- May 22, 2015 OPEN OPEN REC. 2:00 P.M. CLOSE
    Memorial Day -- May 25, 2015 CLOSED CLOSED REC. CLOSE
    Friday -- July 3, 2015 CLOSED CLOSED REC. CLOSE
    Saturday -- Independence Day -- July 4, 2015 CLOSED CLOSED REC. CLOSE
    Labor Day -- September 7, 2015 CLOSED CLOSED REC. CLOSE
    Columbus Day -- October 12, 2015 OPEN OPEN REC. CLOSE
    Veteran's Day -- November 11, 2015 OPEN OPEN REC. CLOSE
    Thanksgiving Day -- November 26, 2015 CLOSED CLOSED REC. CLOSE
    Friday -- November 27, 2015 OPEN TIL 1:00 P.M. OPEN TIL 1:00 P.M. REC. 2:00 P.M. CLOSE
    Christmas Eve Day -- December 24, 2015 OPEN TIL 1:00 P.M. OPEN TIL 1:00 P.M. REC. 2:00 P.M. CLOSE
    Christmas Day -- December 25, 2015 CLOSED CLOSED REC. CLOSE
    New Year's Eve Day -- December 31, 2015 OPEN OPEN REC. 2:00 P.M. CLOSE
    New Year's Day -- January 1, 2016 CLOSED CLOSED REC. CLOSE

    Sentiment: Buy

  • palantir777 palantir777 Jul 2, 2015 9:13 PM Flag

    budrocky, you and any other long that also finds this link to be useful is indeed welcome!

    Sentiment: Buy

  • Reply to

    Latest on the latest

    by rainingdung Jul 2, 2015 6:51 PM
    palantir777 palantir777 Jul 2, 2015 9:06 PM Flag

    so that's how it's done in/at the Manila dump where you reside and reign as "Lord of the Flies"? as usual mumbo jumbo that only you may parlay, priceless!

    Sentiment: Buy

  • palantir777 palantir777 Jul 2, 2015 8:53 PM Flag

    no suprise pup_puta that you're back posting using another alias and still presenting as this mb's low bar as evidenced by the above exercise in grammatical chaos. damn If I didn't forget how entertaining these back forths with an utter moron could be, go figure.

    Sentiment: Buy

  • palantir777 palantir777 Jul 2, 2015 7:34 PM Flag

    now that`s a visual that i admit elicits a chuckle. the couldn`t happen to a more deserving person thing comes to mind as well.

    Sentiment: Buy

  • palantir777 palantir777 Jul 2, 2015 7:32 PM Flag

    dowface/dscorr: androgynous and a moron, life`s gonna come at you sideways for the most part it would seem . if you`re gonna continue speculating in stocks perhaps a Due Diligence class or two may help, you`re gonna need all the help you can get pat.

    Sentiment: Buy

  • www.marketwatch.com/story/navidea-biopharmaceuticals-and-macrophage-therapeutics-to-host-post-international-kshv-conference-summary-webcast-2015-07-02?siteid=nbsh

    Sentiment: Buy

  • palantir777 palantir777 Jul 2, 2015 6:53 PM Flag

    "And, I don't care what the clinical advances are that they identify."
    this statement is an admission of consciously excluding all possibilities relative to the possible success of NAVB`s strategy in the growing of shareholder value/wealth. to consciously exclude all possibilities regardless of the endeavor belies an agenda, in this case a short agenda as expressed by hanovk. the passage of time and a minimal one at that(inmho) will provide the necessary clarity as to the correct speculation. in the mean time the subtle to outright bashes will increase in both frequency and vitriol because of said devolving short agenda as propagated by those individuals with multiple aliases and ZERO integrity. it`s what bashers do, it`s who bashers are...
    c`est la vie and my money is on eespelan`s speculation going forward.

    Sentiment: Buy

  • Reply to

    caught them

    by rainingdung Jul 2, 2015 11:17 AM
    palantir777 palantir777 Jul 2, 2015 11:27 AM Flag

    spew that is absolutely irrelevant to meaningless. hey dungforbrains, gotta give ya credit though for the way ya oversold yourself relative to the basher thing, suggest you keep your day job as a fluff....

    Sentiment: Buy

  • Reply to

    Time to get to work

    by rainingdung Jul 2, 2015 2:53 AM
    palantir777 palantir777 Jul 2, 2015 9:50 AM Flag

    hey, a new fluff in support of obvious bashers, welcome! btw please offer the appropriate grammar/spelling, and conjugations, that is and if ya can break away from the fluff thing....welcome again tool!

    Sentiment: Buy

  • palantir777 palantir777 Jul 2, 2015 9:45 AM Flag

    nice of ya to supply the springboard pat....who says an androgynous whatever can`t be accomadating? lol!

    NAVB / Message Board
    Previous Message Post Message Post a Reply return to message board, top of board
    Msg 8662 of 8662 at 7/2/2015 8:18:07 AM by moneyonomics
    The following message was updated on 7/2/2015 8:33:21 AM.

    macrophage-therapeutics-reports-data. and navidea-announces-clinical-data-...investor presentation July 7- from kent on otl--what other details will McGrath present this evening on translational studies???

    Sentiment: Buy

  • Navidea Biopharmaceuticals, Inc.. NAVB and its subsidiary, Macrophage Therapeutics, Inc., today announced that imaging results from the Manocept™ clinical trial in Kaposi's Sarcoma (KS) and other preclinical studies were presented at the 18th International Workshop on Kaposi's Sarcoma Herpesvirus (KSHV) and Related Agents in Hollywood, Florida. The clinical imaging study, using Tc 99m tilmanocept, a Manocept platform product, in both HIV+ and HIV- patients suggests that KS tumor lesions, both cutaneous and suspected extra-cutaneous sites, can be easily visualized and mapped, demonstrating that this technique may potentially provide a means for routine patient assessment. The results also show that use of Manocept represents a potential therapeutic pathway for targeting tumor associated macrophages (TAMs). Manocept agents are designed to target CD206, which is highly expressed on TAMs and the KS tumor itself. As a potential therapeutic, Manocept could be used as a precision vehicle to deliver payloads to tumor sites throughout the body.
    These pre-clinical and clinical studies support using Kaposi's sarcoma as a model tumor system for evaluating therapeutic approaches for the Manocept platform in other forms of solid tumors," commented Michael Tomblyn, M.D., Navidea's Chief Medical Officer. "They provide evidence that Manocept agents can target CD206 and are internalized into tumor associated macrophages and tumor cells. This along with clinical observations that demonstrate tilmanocept can be used to image KS tumors both externally and internally indicates excellent potential for immunotherapeutic utility.

    Sentiment: Buy

  • Reply to

    NAVB

    by bookerone2000 Jul 2, 2015 8:47 AM
    palantir777 palantir777 Jul 2, 2015 8:56 AM Flag

    more coming tonight longs, bashers carry on, lol!!!!!!!!!!!!!!
    Reinforces Therapeutic Potential of Targeting Activated Macrophages via the CD206 Receptor-- Data also suggest a new origin of KS as a macrophage fusion tumor -
    DUBLIN, Ohio, Jul 02, 2015 (BUSINESS WIRE) -- Navidea Biopharmaceuticals, Inc. (nyse mkt:NAVB) and its subsidiary, Macrophage Therapeutics, Inc., today announced that imaging results from the Manocept™ clinical trial in Kaposi’s Sarcoma (KS) and other preclinical studies were presented at the 18th International Workshop on Kaposi's Sarcoma Herpesvirus (KSHV) and Related Agents in Hollywood, Florida. The clinical imaging study, using Tc 99m tilmanocept, a Manocept platform product, in both HIV+ and HIV- patients suggests that KS tumor lesions, both cutaneous and suspected extra-cutaneous sites, can be easily visualized and mapped, demonstrating that this technique may potentially provide a means for routine patient assessment. The results also show that use of Manocept represents a potential therapeutic pathway for targeting tumor associated macrophages (TAMs). Manocept agents are designed to target CD206, which is highly expressed on TAMs and the KS tumor itself. As a potential therapeutic, Manocept could be used as a precision vehicle to deliver payloads to tumor sites throughout the body.

    Sentiment: Buy

  • Follow
    Navidea Biopharmaceuticals, Inc. (NAVB) Pre-Market Trading
    NAVB $1.73* 0.116.79%
    *Delayed - data as of 07/02/2015 08:39 - Find a broker to begin trading NAVB now Exchange: AMEX
    Industry: Health Care
    Community Rating: Bullish
    View: NAVB Pre-Market
    Jul. 1, 2015 Market Close: $ 1.62 Pre-Market Charts | After Hours Charts
    View most recent trades for the selected time period:
    Pre-Market Volume: Pre-Market High: Pre-Market Low:
    17,632 $ 1.75 $ 1.70

    Sentiment: Buy

  • Reply to

    Time to get to work

    by rainingdung Jul 2, 2015 2:53 AM
    palantir777 palantir777 Jul 2, 2015 7:21 AM Flag

    you write and spell as bad as pup_puta....Is that you pup_puta? lol!!!!!!

    Sentiment: Buy

  • Reply to

    LOAN DUE

    by rainingdung Jul 1, 2015 5:48 PM
    palantir777 palantir777 Jul 2, 2015 7:19 AM Flag

    hey dungforbrains: are you at the masengill shooters again? you`re already operating at a deficit, a product of...#$%$ love? the last thing you need is an over abundance of said consumptive....whatever. shut `er down son, you`re inabilities to bash really make ya boring....what`s up with the "threw life" thing? GD, you`re an uneducated fool aren`t ya?

    "can see you stumble threw life just guessing like most you wont believe the truth so take a look at palantir 777 fascitis he agrees with me, why are you on this site to begin with you can contribute only very little and half of that is fantasy, so take your nickel and go home."

    Sentiment: Buy

  • Reply to

    LOAN DUE

    by rainingdung Jul 1, 2015 5:48 PM
    palantir777 palantir777 Jul 2, 2015 7:10 AM Flag

    hey dungforbrains: as you can see via guidance and even using the made up number of cash on hand you provided($8kk), NAVB clearly makes the finish line/BREAKEVEN(Q1-2016) with room to spare. the real number as to cash on hand($23kk) + the credit line($27kk) +guidance revenue for the year($12kk)=$62kk+- actual available cash, no wonder you had to post such an obvious.....miscalculation, lol. ya only missed the cash actual by a multiple of 7.75, I guess a nickel a bash from ya just ain`t worth what it used to be.
    hang it up moron while your....ahead? lol!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

    Sentiment: Buy

NAVB
1.68+0.06(+3.70%)Jul 2 4:04 PMEDT